From the Guidelines
An Extractable Nuclear Antigen (ENA) panel typically includes tests for antibodies against chromatin, ribosomal P protein, spliceosome small nuclear ribonucleoproteins (Smith), Sjögren syndrome type A antigen (Ro), Sjögren syndrome type B antigen (La), and U1-ribonucleoprotein, as identified in the most recent expert panel proposal 1. The ENA panel is a crucial diagnostic tool for autoimmune disorders, particularly when antinuclear antibody (ANA) test results are positive.
- The panel helps to detect specific autoantibodies associated with various autoimmune conditions, such as systemic lupus erythematosus (SLE), Sjögren's syndrome, and mixed connective tissue disease.
- The most common targets of autoantibodies detected in SLE, as reported in the expert panel proposal, include chromatin, ribosomal P protein, and spliceosome small nuclear ribonucleoproteins (Smith) 1.
- The presence of these antibodies indicates an immune response against the body's own nuclear components, which is a hallmark of autoimmune diseases.
- The ENA panel is usually ordered as a follow-up test to a positive ANA result, providing more specific diagnostic information to guide treatment and management decisions.
- It is essential to note that the ENA panel should be interpreted in the context of clinical presentation and other diagnostic findings, as discrepancies may arise between anti-ENA and ANA results or clinical presentation 1.
From the Research
Extractable Nuclear Antigen (ENA) Panel
An ENA panel is a test used to detect the presence of autoantibodies against specific extractable nuclear antigens. The following antigens are typically included in an ENA panel:
- Jo-1 (histidyl-tRNA synthetase) 2
- Scl-70 (topoisomerase) 2, 3
- SS-A (Sjogren's syndrome A) 2, 3, 4, 5, 6
- SS-B (Sjogren's syndrome B) 2, 3, 4, 5, 6
- Sm (Smith) 2, 3, 4, 5, 6
- Sm/RNP (Smith/Ribonucleoprotein) 2, 3, 4, 5
- RNP (Ribonucleoprotein) 3, 4, 5
Detection Methods
Various methods can be used to detect anti-ENA antibodies, including:
- ELISA (Enzyme-Linked Immunosorbent Assay) 2, 5
- Counterimmunoelectrophoresis 4
- Line immunoassay (LIA) 5
- Fluorescence enzyme immunoassay (EliA) 5
- Double dimension immunodiffusion 6
Clinical Significance
The presence of anti-ENA antibodies can be used to diagnose and monitor various autoimmune diseases, including: